Skip to main content
. 2019 Jul 2;10:421. doi: 10.3389/fendo.2019.00421

Table 1.

Clinical characteristics of participants in our study.

Variablesa Discovery set Validation set Combined set
TC (N = 152) Controls (N = 151) Pa TC (N = 250) Controls (N = 255) Pa TC (N = 402) Controls (N = 406) Pa
Age, years 53.0 ± 8.3 51.5 ± 8.9 0.136 52.2 ± 7.5 51.7 ± 8.8 0.425 52.5 ± 7.8 51.6 ± 8.8 0.117
Female, n (%) 95 (62.5) 88 (58.3) 0.452 153 (61.2) 161 (63.1) 0.654 248 (61.7) 249 (61.3) 0.916
Smoking, n (%) 41 (27.0) 51 (33.8) 0.198 64 (25.6) 78 (30.6) 0.213 105 (28.1) 129 (31.8) 0.076
Alcohol drinking, n (%) 38 (25.0) 52 (34.4) 0.072 66 (26.4) 59 (23.1) 0.396 104 (25.9) 111 (27.3) 0.637
History of DM, n (%) 53 (34.9) 33 (21.9) 0.012 91 (36.4) 59 (23.1) 0.001 144 (35.8) 92 (22.7) < 0.001
BMI, kg/m2 25.2 ± 3.6 24.4 ± 2.2 0.028 25.1 ± 3.5 24.4 ± 2.5 0.016 25.1 ± 3.5 24.4 ± 2.4 0.001
TC subtypes, n (%)
  PTC 117 (77.0) 193 (77.2) 310 (77.1)
  FTC 25 (16.4) 47 (18.8) 72 (17.9)
  MTC 10 (6.6) 2 (0.8) 12 (3.0)
  PDTC and ATC 0 (0) 8 (3.2) 8 (2.0)

PTC, papillary thyroid carcinoma; FTC, follicular thyroid cancer; MTC, medullary thyroid carcinoma; PDTC, poorly differentiated thyroid carcinoma; ATC, anaplastic thyroid carcinoma.

a

Continuous variables were expressed as mean ± SD, and compared by the Student's t-test. Categorical variables were expressed as frequency counts, and compared by the Pearson χ2 test.